VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1650623
Sex: M
Age:
State: CT

Vax Date: 04/16/2021
Onset Date: 04/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Pain in joints of fingers; This is a spontaneous report from a contactable consumer, the parent. A 25-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 16Apr2021 at 10:00, (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history included suspected COVID-19 in March 2020 but did not receive a COVID-19 test and therefore diagnosis was not clinically confirmed. The patient had no known allergies to medications, food or other products. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 16Mar2021 at 11:00 hours, (at the age of 25-year-old) as a single dose for COVID-19 immunisation. On 17Apr2021 at 01:00, the patient experienced pain in joints of fingers. No therapeutic measures were taken as a result of reported event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event pain in joints of fingers was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650624
Sex: F
Age:
State: CA

Vax Date: 03/26/2021
Onset Date: 03/26/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 38-year-old (non-pregnant) female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 38, via an unspecified route of administration, left arm, on Mar 26, 2021, at 13:00, single dose, for COVID-19 immunisation. The patient has no reported medical history. The patient has no known allergies to medications, food or other products. The patient did not receive any medications within two weeks of vaccination. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Mar 26, 2021, at 15:00, patient experienced "pins and needles" feeling in hands, which started about an hour after she received the vaccine. It has not gone away and it has been over 3 weeks. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures not taken as a result of the event. Since the vaccination, patient has not tested for COVID-19. The clinical outcome of "pins and needles" feeling in hands: not resolved (at the time of this report). No follow-up attempts needed. Information about lot/batch number cannot be obtained. No further information expected.

Other Meds:

Current Illness:

ID: 1650625
Sex: M
Age:
State: TX

Vax Date: 04/16/2021
Onset Date: 04/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Body temperature; Result Unstructured Data: Test Result:102.5; Comments: fever spiked at 102.5.

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Difficulty moving due to body pain.; difficulty moving due to body pain; Severe chills 12 hours after shot; High fever, normally run fever at 99, fever spiked at 102.5, fever was very high; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 16Apr2021 at 12:30 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. The medical history included blood pressure high (HBP, under control with medication), post-traumatic stress disorder (PTSD, under control with medication) and high cholesterol (under control with medication). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included citalopram hydrobromide (CELEXA), lisinopril (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN), fenofibrate (MANUFACTURER UNKNOWN) and antacid (unspecified), all from unknown dates and for unknown indications. On 17Apr2021 at 00:15, the patient experienced high fever ( the patient normally ran fevers at 99). After 12 hours of shot, the fever hit with severe chills and fever spiked at 102.5. The patient had difficulty moving due to body pain. The patient understood that these symptoms ran normally with influenza, however, the fever was very high for the patient and the patient did not had influenza. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. On an unknown date, the patient underwent body temperature and tested with a temperature of 102.5 (unspecified unit). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event difficulty moving, body pain, severe chills, high fever and fever spiked at 102.5 was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: CELEXA [CITALOPRAM HYDROBROMIDE]; LISINOPRIL; ATORVASTATIN; FENOFIBRATE

Current Illness:

ID: 1650626
Sex: F
Age:
State: MA

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 24-year-old (non-pregnant) female patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EP6955), at the age of 24, via an unspecified route of administration, left arm, Apr 16, 2021, at 10:00, single dose, for COVID-19 immunisation. The patient has no reported medical history. The patient has no known allergies to medications, food or other products. The patient did not take any concomitant medications. The patient previously received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 24, via an unspecified route of administration, left arm, on Mar 26, 2021, at 10:00, single dose, for COVID-19 immunisation. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Apr 16, 2021, at 21:00, patient experienced fever, headache, nausea, chills and aches. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures taken as a result of the events. Since the vaccination, patient has not tested for COVID-19. The outcome of fever, headache, nausea, chills and aches: not resolved (at the time of this report). No follow-up attempts needed. No further information expected.

Other Meds:

Current Illness:

ID: 1650627
Sex: M
Age:
State: MD

Vax Date: 04/16/2021
Onset Date: 04/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Arm was sore (worse 2nd day); Dizziness after 15 minutes of sitting down; Headaches; Body aches (back); Insomia; Nightmares; Trouble sleeping; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 16Apr2021 at 10:45 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included acid reflux, slight asthma (due to COVID-19), seasonal allergies and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Allergies to medications, food, or other products were reported as not applicable. Concomitant medications included haloperidol (PANDOL), ibuprofen (TABCIN), multi-vitamin (MANUFACTURER UNKNOWN) and ibuprofen (ADVIL); all for unknown indications from unspecified dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 17Apr2021 at 00:00, the patient reported that his arm was sore (worse the second day), dizziness after 15 minutes of sitting down, headaches, body aches (back), insomnia, nightmares and trouble sleeping. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, it was unknown if the patient had been tested for COVID-19. The clinical outcome of the events arm was sore (worse 2nd day), dizziness after 15 minutes of sitting down, headaches, body aches (back), insomnia, nightmares, trouble sleeping was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: PANDOL; TABCIN [IBUPROFEN]; ADVIL [IBUPROFEN]

Current Illness:

ID: 1650628
Sex: F
Age:
State: NY

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: I noticed my left hand wasn't fully functioning (as if my hand had fallen asleep and wasn't fully "awake").; Some slight pain in my arm socket when moving my arm in some directions.; Sometimes, would also get numbness or tinglingdown in arm and in fingers,; Sometimes, I would also get numbness or tingling down my arm and in my fingers.; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 16Apr2021 at 13:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient did not have any known medical history. The patient had no known allergies to food, medication or other product. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included calcium (MANUFACTURER UNKNOWN), ergocalciferol (VITAMIN d2) and multivitamin (MANUFACTURER UNKNOWN) all started on unknown dates and for unspecified indications. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 16Apr2021 at 13:30 the patient experienced the left hand wasn't fully functioning (as if hand had fallen asleep and wasn't fully awake) within minutes of receiving the injection in the upper left arm. About an hour later, she noticed some slight pain in the arm socket when moving arm in some directions. Over the course of the night, the pain (very sharp) became worse to the point where it was excruciating to try to undress for bed. Sometimes, she would also get numbness or tingling down in the arm and in the fingers, similar to after had hit to the funny bone really was hard. She could only sleep on her back because any other position was too painful. On 17Apr2021, the numbness and tingling have stopped, but the arm socket still had sharp pain if moved. So, she kept the arm stable against her body (from elbow up); if that was done, it didn't hurt at all. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the event(s). The clinical outcome of the events numbness in the arm and fingers and tingling were recovered on 17April2021. The clinical outcome of the event pain in arm and arm discomfort was not recovered, at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: CALCIUM; VITAMIN D2

Current Illness:

ID: 1650629
Sex: U
Age:
State:

Vax Date: 04/15/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: two short waves of numbness through his body; This is a spontaneous report received from a non-contactable consumer patient of unspecified age and gender received first dose of bnt162b2 (COMIRNATY,Batch/Lot number was not reported), via an unspecified route of administration on 15Apr2021 as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced two short waves of numbness through his body on 15Apr2021. The outcome of the events was unknown. The patient was suggested to followup with MD if symptoms return. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650630
Sex: F
Age:
State: CA

Vax Date: 04/02/2021
Onset Date: 04/02/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 62-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EW0150), at the age of 62, via an unspecified route of administration, left arm, on Apr 2, 2021, at 08:30, single dose, for COVID-19 immunisation. The patient has no reported medical history. The patient has no allergies to medications, food or other products. Prior to the vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications not reported. On Apr 2, 2021, at 23:45, patient experienced ringing in ears. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the event. The clinical outcome of ringing in ears not resolved at the time of report. No follow-up attempts needed. No further information expected.

Other Meds:

Current Illness:

ID: 1650631
Sex: F
Age:
State: FL

Vax Date: 04/12/2021
Onset Date: 04/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210413; Test Name: Body temperature; Result Unstructured Data: Test Result:103 Units:{DF}; Comments: at 04:00 AM, It took 8 hours for the fever to break but was not under 101 for 2 days

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: I had a fever that was 103; Headache; Body aches; Nausea; Vomiting; Chills; Fatigue; My arm now has a big knot at the injection site.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 12Apr2021 at 15:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and high blood pressure. The patient had known allergies to penicillin and sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and lisinopril (MANUFACTURER UNKNOWN); from an unknown date for unspecified indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22Mar2021 at 15:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 13Apr2021 at 04:00, the day after receiving the shot, the patient experienced fever that was 103 (unspecified units), headache, body aches, nausea, vomiting, chills and fatigue. It took 8 hours for the fever to break but was not under 101 (unspecified units) for 2 days. These side effects lasted 4 days. On an unknown date in Apr2021, after the 4th day, the patient experienced that the arm had a big knot at the injection site. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measure was taken as a result of reported events which included call to the primary care physician (PCP). The clinical outcome of the events fever, headache, body aches, nausea, vomiting, chills and fatigue was recovered on 17Apr2021. The clinical outcome of the event arm had a big knot at the injection site was unknown at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: LEVOTHYROXINE; LISINOPRIL

Current Illness:

ID: 1650632
Sex: F
Age:
State: VA

Vax Date: 03/10/2021
Onset Date: 03/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Irritation of the under eyes; Irritation of eyelids; Symptoms containing redness and dryness, and slight swelling of lids.; Symptoms containing redness and dryness, and slight swelling of lids.; Slight swelling of lids; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EM9809) via an unspecified route of administration in the arm left on 10Mar2021 at 19:15 (at the age of 22-year-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8737) via an unspecified route of administration in the arm left on 31Mar2021 at 19:00 (at the age of 22-year-old) as a single dose for COVID-19 immunisation. The medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medication were not reported. The patient previously took codeine (MANUFACTURER UNKNOWN) and experienced allergy. On 16Mar2021, about a week after first dose, the patient experienced irritation of the under eyes and eyelids, symptoms contained redness and dryness and slight swelling of lids. It was off and on- will be very irritated for 2- 3 days, then got better before become irritated again. It was not subsided before or after the second dose. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events irritation of the under eyes, irritation of eyelids, redness, dryness and slight swelling of lids were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650633
Sex: F
Age:
State: MD

Vax Date: 04/15/2021
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Nausea; Chills; Fever; Headache; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Apr2021 at 14:00(at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to penicillin, sulfonamide and Kiwi; all from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included citalopram hydrobromide (CELEXA) and terbinafine (MANUFACTURER UNKNOWN); both from an unknown date for an unspecified indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 16:00, the patient experienced nausea, chills, fever and headache. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The patient did not receive any treatment for the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea, chills, fever and headache was recovered on an unknown date in Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: CELEXA [CITALOPRAM HYDROBROMIDE]; TERBINAFINE

Current Illness:

ID: 1650634
Sex: F
Age:
State: VA

Vax Date: 04/15/2021
Onset Date: 04/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Swollen under armpit; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 15Apr2021 at 11:45 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: E6955) via an unspecified route of administration in the left arm on 26Mar2021 at 10:00 (at the age of 41-years-old) as a single dose, for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 16:00, the patient experienced swollen under armpit. The event resulted in emergency room/department or urgent care. It was unknown if patient received treatment for the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen under armpit was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650635
Sex: M
Age:
State: ID

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Sudden pain in right ear that would come and go. It started about 3 hrs after the vaccine was received, and continued, with less severity and frequency 24 hrs after receiving the vaccine.; This is a spontaneous report from a non-contactable consumer, the patient. A 65-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Apr2021 at 10:00 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Medical history included acid reflux (esophageal). The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included pantoprazole (MANUFACTURER UNKNOWN), and venlafaxine (MANUFACTURER UNKNOWN) all for an unknown indication from an unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 13:30, the patient experienced sudden pain in right ear that would come and go. It started about three hours after the vaccine was received, and continued, with less severity and frequency 24 hours after receiving the vaccine. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sudden pain in right ear that would come and go that started three hours after the vaccine was received, and continued, with less severity and frequency 24 hours after receiving the vaccine was resolving at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: PANTOPRAZOLE; VENLAFAXINE

Current Illness:

ID: 1650636
Sex: M
Age:
State: TX

Vax Date: 03/01/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: the hives really got bad after the shot (first dose)/hives were really bad event after; This is a spontaneous report from a contactable consumer. A 44-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 01Mar2021 at 12:15 (Batch/Lot Number: EN602) as DOSE 1, SINGLE, then via an unspecified route of administration on 24Mar2021 (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunization. The patient medical history included hives on 26Feb2021 (reported 3 days prior to 1st dose). Concomitant medication included metformin, atorvastatin calcium, levothyroxine, taken for an unspecified indication, start and stop date were not reported. On an unspecified date, the hives really got bad after the shot (first dose). On 24Mar2021, the patient received second dose and hives were really bad event after. The patient was out of hives for almost 4 years and was taking Xolair specialty shot (in fact was on the path to discontinue that) but now the patient has to keep on taking Xolair unless hives get controlled. The outcome of the event was not recovered. Information on the lot/batch number has been requested.

Other Meds: METFORMIN; ATORVASTATIN CALCIUM; LEVOTHYROXINE

Current Illness:

ID: 1650637
Sex: F
Age:
State: GA

Vax Date: 04/15/2021
Onset Date: 04/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: hematomas; bruising on knees, ankles; intense headache; fatigue; some minor body aches; bruising on knees, ankles, and thighs; This is a spontaneous report from a contactable consumer, the patient. A 41-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 15Apr2021 at 09:30 (at the age of 41-years-old), as a single dose for COVID-19 immunisation. The patient had not reported any other health issues. The patient had no known allergies to medications, food or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 17Apr2021 at 08:00, the patient experienced hematomas, bruising on knees, bruising on ankles and thighs (more appear throughout the day), intense headache, fatigue with some minor body aches. Therapeutic measures were not taken as a result of the event. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event hematomas, bruising on knees, ankles and thigh, intense headache, fatigue and some minor body aches was not resolved/ongoing. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650638
Sex: F
Age:
State: TN

Vax Date: 04/05/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Swollen, sore rash occurred at injection site; sore rash occurred at injection site; sore rash occurred at injection site; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the arm left on 05Apr2021 (at the age of 25-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On14Apr2021, exactly 9 days after the vaccination, the patient experienced swollen, sore rash that occurred at the injection site. The events did not result in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen, sore rash occurred at the injection site were recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650639
Sex: M
Age:
State:

Vax Date: 04/06/2021
Onset Date: 04/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: 5 Days after second dose patient developed a large red rash on both arms from elbow to wrist, slightly on both knees and thighs and also on both ankles and top of feet; Raised rash on both arms from elbow to wrist,; 5 Days after second dose patient developed a large red rash on both arms from elbow to wrist, slightly on both knees and thighs and also on both ankles and top of feet; Itchy rash; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the arm left on 06Apr2021 at 15:30 (at the age of 36-year-old), as a single dose for COVID-19 immunisation. Medical history included asthma, since unknown date. The patient had no known allergies. Concomitant medications included SINGULAIR on an unknown date for unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 16Mar2021 at 16:00 (at the age of 36-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 15:00, five days after second dose, the patient developed a large red, raised rash on both arms from elbow to wrist, slightly on both knees and thighs and also on both ankles and top of feet. It was itchy and warm. It started fading after 24 hours. Therapeutic measures were taken as a result of these events and included treatment with cortisone 10 and benadryl. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events large red, raised rash on both arms from elbow to wrist, slightly on both knees and thighs and also on both ankles and top of feet. It was itchy and warm were recovered on an unknown date in Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds: SINGULAIR

Current Illness:

ID: 1650640
Sex: M
Age:
State: CA

Vax Date: 04/05/2021
Onset Date: 04/07/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Ear ringing; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 13:15 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. The patient did not receive other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 00:00, the patient experienced ear ringing persistent, low level, and cyclical in pitch, but very noticeable. The event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the event. The clinical outcome of the event ear ringing was not resolved at the time the report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650641
Sex: F
Age:
State: TX

Vax Date: 04/06/2021
Onset Date: 04/07/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: The following ady, i have headaches on the back part of my head comes and goes with Tylenol.; The body ache comes and goes with Tylenol; Dizziness lingers for7 days now. Even with pain reliever.; Lightheadedness lingers for7 days now. Even with pain reliever.; Headaches is worsening; I have chills on the 30th hour. The following day, I have mostly occasional chills; I have fevers on the 30th hour; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Apr2021 at 14:30 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known allergies to latex. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) and atorvastatin (MANUFACTURER UNKNOWN) indicated for unknow, on unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Mar2021 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient had not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021 at 15:45 the patient experienced chills and fevers on the thirty hours. On 08Apr2021, the following day, patient experienced mostly headaches, body aches and occasional chills. The body ache and headache on the back part of head comes and goes with tylenol. The dizziness and lightheadedness lingers for seven days, even with pain reliever, headaches was worsening. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of occurred events and included treatment with tylenol and even with pain reliever. The clinical outcome of the events chills, fevers, headaches, body aches, dizziness, lightheadedness and headaches was worsening was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: LISINOPRIL; ATORVASTATIN

Current Illness:

ID: 1650642
Sex: F
Age:
State: CA

Vax Date: 04/11/2021
Onset Date: 04/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data: Test Date: 20210412; Test Name: Body temperature; Result Unstructured Data: Test Result:99.3 Units:{DF}; Comments: Fever 99.3

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Right cheek inflamed; redgums on the right side inflamed; hurt to chew; Slight and constant pain/ pressure on right ear drum; Fever 99.3; Felt hot to touch but no fever; Slight runny nose; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 11Apr2021 at 13:15 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history reported that the patient was obese and had allergies to food with soy. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 12:00, the patient had her right cheek inflamed and red gums on the right side inflamed and hurt to chew, slight and constant pain/ pressure on right ear drum, fever 99.3 was the highest, felt hot to touch but no fever and slight runny nose. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events right cheek inflamed, redgums on the right side inflamed, hurt to chew, slight and constant pain/ pressure on right ear drum, fever 99.3, felt hot to touch but no fever and slight runny nose were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650643
Sex: U
Age:
State: OR

Vax Date: 04/10/2021
Onset Date: 04/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Very sore arm; Saw black spots night of, saw neon green spots morning after; This is a spontaneous report from a non-contactable consumer, the patient. A patient of unknown age and gender received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 10Apr2021 at 12:30 (at an unknown age) as a single dose for COVID-19 immunisation. Medical history of the patient was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included vitamins from an unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 19:00, the patient experienced very sore arm and "saw black spots night of, saw neon green spots morning after". Therapeutic measures were not taken as a result of the event(s). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events very sore arm and "saw black spots night of, saw neon green spots morning after" were unknown at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650644
Sex: M
Age:
State:

Vax Date: 04/09/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210413; Test Name: PCR; Test Result: Negative ; Comments: Nasal swab

Allergies:

Symptom List: Unevaluable event

Symptoms: Swollen lymph node; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 16:00 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no allergies to medications, food, or other products. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 16:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021, the patient underwent PCR test for COVID-19 and the result was negative. On 14Apr2021, the patient experienced swollen lymph node at upper left chest near neck. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the event swollen lymph node was not resolved at the time of report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1650645
Sex: F
Age:
State: FL

Vax Date: 03/19/2021
Onset Date: 03/19/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Dental x-ray; Result Unstructured Data: Test Result:Unknown result

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Numbness in lips; Tingling sensation throughout body; Administration site: Left leg; This is a spontaneous report from a non-contactable consumer, the patient. A 66-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left leg on 19Mar2021 at 12:15 (at the age of 66-years-old) as a single dose for COVID-19 immunisation and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 09Apr2021 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure (BP). The patient had known allergies to amoxicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021, the patient experienced numbness in lips and tingling sensation throughout body. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events which included treatment with dental x-ray and PC visit to check for sign of ill. On an unknown date, the patient underwent dental x-ray and the result was unknown. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events numbness in lips and tingling sensation throughout body was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650646
Sex: M
Age:
State: NY

Vax Date: 02/01/2021
Onset Date: 03/02/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210302; Test Name: Heart rate; Result Unstructured Data: Test Result:Elevated; Test Date: 20210315; Test Name: Nasal Swab; Test Result: Negative ; Comments: Nasal swab

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Elevated heart rate; Tingling in feet; Lack of sleep; Loss of appetite; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the arm left on an unknown date in Feb2021 at 08:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications received within 2 weeks of vaccination included lisinopril dihydrate (LISINOPRIL), cyanocobalamin (B-12), unspecified multivitamin (MANUFACTURER UNKNOWN) and hydrachloricide; all taken for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 02Mar2021 at 20:00, the patient experienced elevated heart rate, loss of appetite, tingling in feet and lack of sleep. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. Since the vaccination, the patient had been tested for COVID-19. On 15Mar2021, the patient underwent nasal swab COVID-19 test and the result was negative. The clinical outcome of the events elevated heart rate, loss of appetite, tingling in feet and lack of sleep were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LISINOPRIL; B 12

Current Illness:

ID: 1650647
Sex: F
Age:
State: AZ

Vax Date: 04/11/2021
Onset Date: 04/12/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Extreme Nausea, Fatigue, Bad taste in mouth and fever chills for 4 full days post vaccine; Extreme Nausea, Fatigue, Bad taste in mouth and fever chills for 4 full days post vaccine; Extreme Nausea, Fatigue, Bad taste in mouth and fever chills for 4 full days post vaccine; Extreme Nausea, Fatigue, Bad taste in mouth and fever chills for 4 full days post vaccine; This is a spontaneous report from a contactable consumer. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 11Apr2021 at 13:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no known allergies to medications, food, or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021, the patient experienced extreme nausea, fatigue, bad taste in mouth and fever chills for four full days post vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events extreme nausea, fatigue, bad taste in mouth and fever chills for four full days post vaccine was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650648
Sex: M
Age:
State: MA

Vax Date: 04/13/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Headache; Feeling of malaise; Sore joints (wrists, elbows, knees); Fatigue; Feel like a mental fog; This is a spontaneous report from a non-contactable consumer, the patient. A 26-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the right arm on 13Apr2021 at 08:45 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included fruit allergy (Mangoes). Concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 21:30, the patient experienced headache, feeling of malaise, sore joints: wrists; elbows; knees, fatigue, felt like in a mental fog. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events headache, feeling of malaise, sore joints: wrists; elbows; knees, fatigue, felt like in a mental fog was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness: Fruit allergy (Mangos)

ID: 1650649
Sex: F
Age:
State: IL

Vax Date: 03/26/2021
Onset Date: 04/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Swollen lymph nodes in upper right chest near collarbone; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the right arm on 26Mar2021 at 13:30 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included herpes simplex virus (HSV) and latex allergy. Concomitant medications included lysine (MANUFACTURER UNKNOWN) and women's multi-vitamin (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 12:00 the patient experienced swollen lymph nodes in upper right chest near collarbone. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event swollen lymph nodes in upper right chest near collarbone was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LYSINE

Current Illness:

ID: 1650650
Sex: F
Age:
State: PA

Vax Date: 04/13/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 64-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 64, via an unspecified route of administration, left arm, on Apr 13, 2021, at 00:00, single dose for COVID-19, immunisation. Medical history included COVID-19. Prior to the vaccination, patient diagnosed with COVID-19. Concomitant medications not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Apr 13, 2021, at 00:00, patient experienced underarm pain and swelling. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures taken as a result of the events. Since the vaccination, patient has not tested for COVID-19. The clinical outcome of the underarm pain and swelling: not recovered (at the time of this report). No follow-up attempts needed. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650651
Sex: F
Age:
State: IL

Vax Date: 04/13/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210323; Test Name: PCR; Test Result: Negative ; Comments: "Nasal Swab

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Dizzy; Body aches and pains/ sore all over; Headache; Sore arm; Chills; Joint pain; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 13Apr2021 at 12:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included meloxicam (MANUFACTURER UNKNOWN), trazodone hydrochloride (DEPRAX) and amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) and statin (MANUFACTURER UNKNOWN all were from an unknown date for unknown indications and unknown if on going. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 16Mar2021 at 12:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient previously took pneumococcal vaccine and experienced allergy to vaccine. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Mar2021, the patient underwent SARS-CoV-2 test and the result was negative. On 13Apr2021 at 14:30, the patient experienced dizzy, body aches and pains, headache, sore arm, sore all over, chills and joint pain. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events of dizzy, body aches and pains, headache, sore arm, sore all over, chills and joint pain were not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained

Other Meds: MELOXICAM; DEPRAX [TRAZODONE HYDROCHLORIDE]; ADDERALL

Current Illness:

ID: 1650652
Sex: F
Age:
State: AZ

Vax Date: 04/04/2021
Onset Date: 04/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Constant, low-mid grade headache daily since vaccination; Injection site randomly starting to hurt about 2 weeks after vaccination; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04Apr2021 at 16:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), sertraline hydrochloride (ZOLOFT), vitamin d nos (MANUFACTURER UNKNOWN) and unspecified birth control; all were taken for an unknown indication and within two weeks of the vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 05Apr2021 the patient experienced constant, low-mid grade headache daily since vaccination. On an unknown date in Apr2021, about 2 weeks after vaccination, the patient experienced injection site randomly starting to hurt. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events constant, low-mid grade headache daily since vaccination and injection site randomly starting to hurt were not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LEVOTHYROXINE; ZOLOFT; VITAMIN D NOS

Current Illness:

ID: 1650653
Sex: M
Age:
State: FL

Vax Date: 04/13/2021
Onset Date: 04/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Injection site pain; Tiredness; Headache; Muscle pain; Chills; Joint pain; Fever; Injection site swelling; Nausea; Feeling unwell; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 13Apr2021 at 17:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had penicillin allergy. The patient did not receive any other medications within 2 weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 12:00, the patient experienced injection site pain, tiredness, headache, muscle pain, chills, joint pain, fever, injection site swelling, nausea and felt unwell. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of adverse event and included treatment with acetaminophen. The clinical outcome of the events injection site pain, tiredness, headache, muscle pain, chills, joint pain, fever, injection site swelling, nausea and felt unwell was resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650654
Sex: M
Age:
State:

Vax Date: 04/03/2021
Onset Date: 04/04/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: 3 days of severe diarrhea followed by dehydration; 3 days of severe diarrhea followed by dehydration; This is a spontaneous report from a contactable consumer. This 31-Year-Old male consumer (patient) received bnt162b2 (BNT162B2, Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number EP7533), dose 1 via an unspecified route of administration, administered in Arm Right on 03Apr2021 17:00 as DOSE 1, SINGLE for covid-19 immunisation (Age at vaccination 31 Years). Medical history and concomitant medications were not reported. No other vaccine in four weeks. COVID not tested post vaccination. No known allergies. No other medical history. On 04Apr2021 20:00 patient experienced 3 days of severe diarrhoea followed by dehydration. No treatment was received for events. The outcome of event was recovered on an unspecified date in Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1650655
Sex: M
Age:
State: CT

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: sweats; chills; Head Rush immediately following the injection; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 16Apr2021 at 14:30 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history included tuberous sclerosis. The patient had no known allergies to medications, food, or other products. The patient did not receive any medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 26Mar2021 at 15:15 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 14:30, the patient experienced head rush immediately following the injection. On 17Apr2021 at 02:00, the patient experienced chills and at 11:00 experienced sweats. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events head rush immediately following the injection, chills and sweats were resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650656
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: This is a spontaneous report from a noncontactable other healthcare professional. A 50-year-old (non-pregnant) female patient received an unknown dose number of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 50, via an unspecified route of administration, on an unknown date in 2021, single dose, for COVID-19 immunisation. Medical history and concomitant medications not reported. On an unknown date in 2021, patient experienced fever. The clinical outcome of the event fever: unknown (at the time of this report). No follow-up attempts possible. Information about lot/batch number cannot be obtained. No further information expected.

Other Meds:

Current Illness:

ID: 1650657
Sex: F
Age:
State: TN

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Slight headache; Ear popping; Pressure in face; Joint pain; Dizziness; itchiness at injection site; Tiredness; Chills; Weird dreams; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the right arm on 16Apr2021 at 09:45 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 22:00, the patient experienced slight headache, ear popping, pressure in the face, joint pain, dizziness, itchiness at injection site, tiredness, chills and weird dreams. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events slight headache, ear popping, pressure in the face, joint pain, dizziness, itchiness at injection site, tiredness, chills and weird dreams were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650658
Sex: F
Age:
State: MA

Vax Date: 04/15/2021
Onset Date: 04/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Whole body aches; Sore arm at injection site; Chills; Muscle fatigue; Headache; Nausea; Generally feeling unwell; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the right arm on 15Apr2021 at 16:15 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included loratadine (CLARITIN) or acetylsalicylic acid, caffeine, paracetamol (EXCEDRIN) for unknown indication from an unknown date. The patient previously received ceftriaxone (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 13:00 the patient experienced whole body aches, sore arm at injection site, chills, muscle fatigue, headache and generally feeling unwell. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events whole body aches, sore arm at injection site, chills, muscle fatigue, headache and generally feeling unwell were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: CLARITIN [LORATADINE]; EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL]

Current Illness:

ID: 1650659
Sex: M
Age:
State:

Vax Date: 02/26/2021
Onset Date: 03/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Diagnosed with Shingles; This is a spontaneous report from a non-contactable consumer, the patient. A 60-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EN6202) via an unspecified route of administration in the left arm on 26Feb2021 at 11:45 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included cancer. The patient previously received sulfur (MANUFACTURER UNKNOWN), on unknown dates for unspecified indications and experienced drug allergy. Concomitant medications included losartan potassium (LOSARTIN) and amlodipine besilate (AMLODIPINE), both for unknown indication, from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 10Mar2021, 10 days after receiving 1st dose of vaccination the patient was diagnosed with shingles. Therapeutic measures were taken for the reported event of shingles and treatment drugs included valtrex. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event shingles was recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: LOSARTIN; AMLODIPINE

Current Illness:

ID: 1650660
Sex: F
Age:
State: MA

Vax Date: 04/17/2021
Onset Date: 04/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: She is experiencing a sore arm; Headache; Low grade fever; Feels tired; This is a spontaneous report from a contactable consumer. A 16-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 17Apr2021 at 10:45 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included pantoprazole (MANUFACTURER UNKNOWN) of 20mg from an unknown date for unknown indication and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 27Mar2021 at 10:30 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 18Apr2021 at 10:00, the patient experienced sore arm, headache, low grade fever, and felt tired. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of reported event which included treatment with paracetamol (TYLENOL). The clinical outcome of events sore arm, headache, low grade fever, and feels tired were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: PANTOPRAZOLE

Current Illness:

ID: 1650661
Sex: U
Age:
State: VA

Vax Date: 04/15/2021
Onset Date: 04/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: I have experienced loss of taste. Most notable in loss of salt taste; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old patient of unknown gender received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8739) via an unspecified route of administration in the left arm on 15Apr2021 at 14:00, (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19, as prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not have any allergies to medications, food, or other products. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) for an unknown indication and since an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the right arm on 23Mar2021 at 15:00 (at the age of 59-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 17Apr2021 at 14:00, the patient experienced experienced loss of taste, most notable in loss of salt taste. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported event. The clinical outcome of the event loss of taste, most notable in loss of salt taste was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LISINOPRIL

Current Illness:

ID: 1650662
Sex: M
Age:
State: NY

Vax Date: 04/14/2021
Onset Date: 04/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Swollen / hardened glands in left collarbone and lower neck area; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 16:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient was not reported. Patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included sertraline (MANUFACTURER UNKNOWN), finasteride (MANUFACTURER UNKNOWN), turmeric (MANUFACTURER UNKNOWN) all from an unknown date for an unspecified indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 20Mar2021 at 10:30 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 09:00, the patient experienced swollen / hardened glands in left collarbone and lower neck area. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen / hardened glands in left collarbone and lower neck area was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: SERTRALINE; FINASTERIDE

Current Illness:

ID: 1650663
Sex: F
Age:
State: TN

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Arm pit/ lymph node pain; Arm pit/ lymph node pain; "Dose 1, administration date: 29Mar2021 at 08:30; Dose 2, administration date: 16Apr2021 at 18:00"; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 16Apr2021 at 18:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included depression. Concomitant medications included fluoxetine hydrochloride (PROZAC), quetiapine fumarate (SEROQUEL) and amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL); all taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 29Mar2021 at 08:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 18:00 the patient had "Dose 1, administration date: 29Mar2021 at 08:30; Dose 2, administration date: 16Apr2021 at 18:00". On 17Apr2021 at 03:00, the patient experienced arm pit/ lymph node pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events arm pit/ lymph node pain was resolving at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: PROZAC; SEROQUEL; ADDERALL

Current Illness:

ID: 1650664
Sex: M
Age:
State: MN

Vax Date: 04/16/2021
Onset Date: 04/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Swelling was painful, in arm pit extending from torso (not from arm); Swelling under the arm, same arm shot received; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the right arm on 16Apr2021 at 12:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously took prochlorperazine (MANUFACTURER UNKNOWN) on an unknown date for unknown indication and experienced drug allergy. The patient previously took BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the right arm on 26Mar2021 at 12:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. On 18Apr2021 at 15:00 the patient experienced swelling under the arm-same arm shot received, swelling was painful, in armpit extending from torso (not from arm). Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swelling under the arm-same arm shot received(swelling), swelling was painful, in armpit (armpit pain) were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650665
Sex: M
Age:
State: IL

Vax Date: 04/03/2021
Onset Date: 04/04/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Rash on inner thighs.; Both thighs small pimple like rash.; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 03Apr2021 at 12:45 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food and other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 12:00, the patient experienced rash on inner thighs, appeared next day and both thighs small pimple like rash that eased after a couple of days but still there a little bit. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events rash on inner thighs, appeared next day and both thighs small pimple like rash was recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650666
Sex: F
Age:
State: MI

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Fatigue; Body aches; Headache; Injection site soreness; Brain fog; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN7533) via an unspecified route of administration in the left arm on 31Mar2021 at 12:15 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included sjogren's syndrome and arthritis. The patient had no known allergies to medications, food or other products. Prior to vaccination, patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 10Mar2021 at 13:15 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. On 31Mar2021 at 17:30 the patient experienced fatigue, body aches, headache, injection site soreness and brain fog. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events fatigue, body aches, headache, injection site soreness and brain fog were recovered on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650667
Sex: M
Age:
State: CT

Vax Date: 04/08/2021
Onset Date: 04/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 202104; Test Name: Nasal Swab; Result Unstructured Data: Test Result:UNKNOWN RESULTS

Allergies:

Symptom List: Vomiting

Symptoms: Numbness on the left side of the face; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 08Apr2021 at 15:15 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021 at 15:00, the patient experienced numbness on the left side of the face. Since the vaccination, the patient had been tested for COVID-19. On an unknown date in Apr2021, the patient underwent nasal swab test for COVID-19 and the result was unknown. The clinical outcome of the event numbness on the left side of the face was unknown at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1650668
Sex: F
Age:
State: IN

Vax Date: 04/13/2021
Onset Date: 04/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Pain arm and muscles; Pain arm and muscles; This is a spontaneous report from a contactable healthcare professional, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right arm on 13Apr2021 at 13:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. On an unknown date in Apr2021, the patient experienced pain in arm and muscles. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events pain arm and muscles were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650669
Sex: M
Age:
State: CA

Vax Date: 04/17/2021
Onset Date: 04/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Acute onset of spinning; Acute onset of dizziness; This is a spontaneous report from a contactable nurse, the patient. A 54-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 17Apr2021 at 11:00 (at the age 54-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, pre-diabetic, pituitary adenoma, vertigo, migraine, uveitis and hyperlipidemia. Concomitant medications included acetylsalicylic acid (ASPIRIN), amlodipine besilate (NORVASC), rosuvastatin (MANUFACTURER UNKNOWN), multivitamin injection (MANUFACTURER UNKNOWN), gummy vitamin (MANUFACTURER UNKNOWN) and escitalopram oxalate (LEXAPRO) all for unknown indications from unknown dates and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 18Apr2021 at 08:30, after the 24 hours of vaccination, the patient experienced acute onset of spinning and dizziness. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events acute onset of spinning and dizziness was unknown at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: ASPIRIN [ACETYLSALICYLIC ACID]; NORVASC; ROSUVASTATIN; LEXAPRO

Current Illness:

ID: 1650670
Sex: F
Age:
State: MA

Vax Date: 04/15/2021
Onset Date: 04/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Rash that was on neck, collar bone, bottom of head hair line, under arms, my groin area, sides, stomach, back , butt, breast.; Felt slightly nauseous; Felt slightly nauseous and light headed but did not throw up.; Rash was itchy and raised.; Rash was itchy and raised.; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EW0161) via an unspecified route of administration in the left arm on 15Apr2021 at 14:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Other medical history was reported as none. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included fluticasone propionate (FLOVENT HFA), lisdexamfetamine mesilate (VYVANSE) and 365 prenatal vitamin (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 00:00, the patient experienced rash that was on neck, collar bone, bottom of head hair line, under arms, groin area, sides, stomach, back, butt and breast, the patient felt slightly nauseous and light headed but did not throw up, rash was itchy and raised. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included treatment with Benadryl pill, hydrocortisone cream on rash area and teledoc appointment recommended treatment with xyzal antihistamine. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rash that was on neck, collar bone, bottom of head hair line, under arms, groin area, sides, stomach, back, butt and breast, felt slightly nauseous and light headed but did not throw up, rash was itchy and raised was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: FLOVENT HFA; VYVANSE

Current Illness:

ID: 1650671
Sex: F
Age:
State: WA

Vax Date: 04/06/2021
Onset Date: 04/07/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Fatigued 24 hours later, weakness in muscles.; Fatigued 24 hours later, weakness in muscles.; This is a spontaneous report from a contactable healthcare professional, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0153) via an unspecified route of administration in the left arm on 06Apr2021 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines. The patient previously took amoxicillin; clavulanic acid (AUGMENTIN) (reported as Ogmenton) for unknown indication on unknown date and experienced drug allergy. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient felt fatigued 24 hours later, weakness in muscles on 07Apr2021. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events felt fatigued 24 hours later, weakness in muscles was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1650672
Sex: F
Age:
State: NC

Vax Date: 04/07/2021
Onset Date: 04/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Rash/hives on inner thighs, insideknee/upper calf, outside upper arms.Both arms and both legs.; hives on inner thighs, insideknee/upper calf, outside upper arms.Both arms and both legs.Red, itchy,slightly swollen; Rash/hives on inner thighs, insideknee/upper calf, outside upper arms.Both arms and both legs. Red; itchy; slightly swollen; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 07Apr2021 at 11:45 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high and obesity. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 20Mar2021 at 13:45 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), cannabidiol (MANUFACTURER UNKNOWN), loratadine (CLARITIN) and oral contraceptive nos (MANUFACTURER UNKNOWN); all were from unknown date and for unspecified indication. On 17Apr2021 at 06:00 the patient experienced rash/hives on inner thighs, inside knee/upper calf, outside upper arms. Both arms and both legs. Red, itchy, slightly swollen. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as the result of adverse events and included treatment with Benadryl. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rash/hives on inner thighs, inside knee/upper calf, outside upper arms. Both arms and both legs. Red, itchy, slightly swollen were resolving at the time report. No follow-up attempts are needed. No further information is expected.

Other Meds: LISINOPRIL; CANNABIDIOL; CLARITIN [LORATADINE]; ORAL CONTRACEPTIVE NOS

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am